Debate

DOI: 10.4244/EIJ-E-24-00004

Prophylactic stenting of vulnerable plaques: pros and cons

Duk-Woo Park1, MD, PhD; Hoyun Kim1, MD; Ayesha Singh2, MD; David L. Brown2,3, MD, PhD

Introduction

The majority of acute coronary syndromes (ACS) are caused by the rupture or erosion of coronary atherosclerotic plaques. In patients with myocardial infarction (MI), recurrent events tend to accrue despite the implementation of secondary prevention measures, which mainly consist of pharmacotherapy. During the last decade, advances in intravascular imaging (i.e., intravascular ultrasound [IVUS], optical coherence tomography [OCT], and near-infrared spectroscopy [NIRS]) led to the identification of morphological features that define “vulnerable plaques” and are linked to higher rates of cardiovascular events. It has been hypothesised that preventive stenting might passivate these lesions, preventing the occurrence of plaque-related acute coronary syndromes. However, stenting can be also associated with adverse outcomes, and no solid evidence is currently available on its use in this sort of “primary prevention” setting. As such, the optimal management of vulnerable plaques has not been established so far and is currently a matter of debate.

Pros

Duk-Woo Park, MD, PhD; Hoyun Kim, MD

Thrombosis of lipid-rich thin-capped atherosclerotic lesions (“vulnerable plaques” [VP]) is the cause of most ACS and unexpected sudden cardiac deaths1....

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 5
Mar 4, 2024
Volume 20 Number 5
View full issue


Key metrics

Suggested by Cory

Viewpoint

10.4244/EIJ-D-22-00397 Oct 21, 2022
Skating on thin ice: searching for vulnerable plaques
Prati F et al
free

Editorial

10.4244/EIJ-E-22-00051 Jan 23, 2023
What makes a plaque rupture? A simple answer seems too much to ask for
Achenbach S
free

10.4244/EIJV15I9A138 Oct 4, 2019
Ruptured and healed atherosclerotic plaques: breaking bad?
Amabile N and Veugeois A
free

10.4244/EIJV8I1A3 May 15, 2012
When the doctor needs an engineer to be the matchmaker
Patel P and Chen Z
free

Letter to the editor

10.4244/EIJ-D-24-00560 Aug 19, 2024
Letter: Identifying vulnerable coronary atherosclerotic plaques: from theory to practice
Dimitriadis K et al

CLINICAL RESEARCH

10.4244/EIJV11I3A59 Jul 20, 2015
Serial optical coherence tomography imaging of ACS-causing culprit plaques
Souteyrand G et al
free
Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved